A drug used to treat severe psoriasis. Etretinate (Tegison) is an oral retinoid, a class of drugs derived from retinoic acid (vitamin A1). Etretinate is not recommended for use by a woman who is pregnant because it can cause birth defects in a fetus.
A tretinoin drug formerly used to treat severe recalcitrant psoriasis.
Etretinate, also known as acitretin, is a retinoid drug chemically related to vitamin A. It finds primary use in treating severe psoriasis, a skin condition characterized by thickened patches of red and inflamed skin. Additionally, etretinate is occasionally employed to treat other disorders that cause excessive skin thickening, like ichthyosis. The drug works by reducing the production of keratin, the protein responsible for forming the tough, outer layers of the skin.
Etretinate may lead to liver damage and an increase in blood fats. It is crucial to avoid taking this drug during pregnancy as it can harm the fetus.